WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AMGN

Based on 10 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$240.00-12.26%
Avg Forecast
$315.70+15.41%
Max Forecast
$360.00+31.61%

Should I buy or sell AMGN stock?

Based on 10 analysts offering ratings for Amgen Inc.
Buy
Strong Buy
4 analysts 40%
Buy
3 analysts 30%
Hold
3 analysts 30%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AMGN stock forecasts and price targets.

AMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-02-08
Morgan Stanley
Top 7%
94
HoldMaintains$278.00+1.63%2024-02-07
Oppenheimer
Top 3%
98
BuyReiterates$350.00+27.95%2024-02-01
Daiwa Capital
Bottom 45%
45
Strong BuyUpgrades$320.00+16.98%2023-12-21
BMO Capital
Top 25%
76
BuyUpgrades$326.00+19.18%2023-12-19
Deutsche Bank
Top 33%
68
HoldInitiates Coverage On$240.00-12.26%2023-11-09

1 of 1

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
N/A
Industry
15.58%
Market
35.5%

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
N/A
Industry
5.85%

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$32.8B+16.34%
Avg 2 year Forecast
$34.0B+20.77%
Avg 3 year Forecast
$34.6B+22.64%
AMGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
18.5%
Industry
71.96%
Market
21.77%
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.17%
Industry
8.73%
Market
10.16%
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMGN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMGN$273.54$315.70+15.41%Buy
PFE$26.32$34.43+30.81%Buy
SNY$47.69$55.00+15.33%Hold
BMY$48.99$55.73+13.75%Hold
NVS$97.28$114.00+17.19%Hold
View Top General Drug Manufacturer Stocks

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 10 analysts, 4 (40%) are recommending AMGN as a Strong Buy, 3 (30%) are recommending AMGN as a Buy, 3 (30%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 0 (0%) are recommending AMGN as a Strong Sell.

If you're new to stock investing, here's how to buy Amgen stock.

What is AMGN's revenue growth forecast for 2024-2026?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 7.17% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Amgen's revenue in 2024 is $28,190,000,000.On average, 11 Wall Street analysts forecast AMGN's revenue for 2024 to be $17,575,693,483,017, with the lowest AMGN revenue forecast at $17,320,898,880,320, and the highest AMGN revenue forecast at $17,856,281,862,419. On average, 11 Wall Street analysts forecast AMGN's revenue for 2025 to be $18,245,513,865,107, with the lowest AMGN revenue forecast at $17,435,585,525,134, and the highest AMGN revenue forecast at $19,117,299,036,472.

In 2026, AMGN is forecast to generate $18,527,293,056,307 in revenue, with the lowest revenue forecast at $16,596,872,445,069 and the highest revenue forecast at $19,132,840,684,601.

What is AMGN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AMGN) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.85%.

What is AMGN's Price Target?

According to 10 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $315.70, with the highest AMGN stock price forecast at $360.00 and the lowest AMGN stock price forecast at $240.00.

On average, Wall Street analysts predict that Amgen's share price could reach $315.70 by Apr 17, 2025. The average Amgen stock price prediction forecasts a potential upside of 15.41% from the current AMGN share price of $273.54.

What is AMGN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AMGN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.